Testing effectiveness (Phase 2)Study completedNCT02078102
What this trial is testing
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Sherif S. Farag 38